Actually, we have the Quebec life sciences strategy, but no such strategy exists for all of Canada. As you were saying, because of that lack of strategic and holistic vision, the price of drugs is seen strictly as a cost rather than an input from a therapeutic perspective.
The PMPRB claims that it will have no impact on drug accessibility and claiming otherwise will fuel a pro-pharma campaign, if not a misinformation campaign.
What is your opinion about the matter?